Ironwood Pharmaceuticals (IRWD) Receivables - Other (2010 - 2020)

Ironwood Pharmaceuticals has disclosed Receivables - Other across 11 years of filings, most recently posting $73.4 million for Q1 2020.

• Receivables - Other for Q1 2020 came in at $73.4 million, up 5.92% year-over-year; the trailing twelve-month figure through Mar 2020 was $73.4 million (up 5.92% YoY), and the FY2019 annual result was $106.0 million, up 76.61% from the prior year.
• Receivables - Other came in at $73.4 million for Q1 2020 at Ironwood Pharmaceuticals, down from $106.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $106.0 million in Q4 2019 to a low of $50.0 million in Q1 2017.
• The 5-year median for Receivables - Other is $65.7 million (2018), against an average of $68.2 million.
• Across the five-year window, Receivables - Other soared 99.68% in 2016 and retreated 27.2% in 2018, its largest moves.
• Ironwood Pharmaceuticals' Receivables - Other stood at $63.9 million in 2016, then increased by 23.54% to $79.0 million in 2017, then dropped by 24.02% to $60.0 million in 2018, then soared by 76.61% to $106.0 million in 2019, then plunged by 30.73% to $73.4 million in 2020.
• The last three Receivables - Other figures came in at $73.4 million (Q1 2020), $106.0 million (Q4 2019), and $94.6 million (Q3 2019), per Business Quant data.